PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats
- 1 February 2005
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 21 (4) , 1070-1076
Abstract
Persistent suppression of N‐methyl‐d‐aspartate (NMDA) receptor function produces enduring structural changes in neocortical and limbic regions in a pattern similar to changes reported in schizophrenia. This similarity suggests that chronic NMDA receptor antagonism in animals may represent a useful model of neurobiological and related cognitive deficits in schizophrenia. Schizophrenia is associated with impairments in frontal lobe‐dependent cognitive functions, including working memory and attentional shifting. Deficits in attention and executive function have not been well characterized in animal models of schizophrenia using chronic NMDA receptor antagonist administration. We investigated whether subchronic systemic administration of the NMDA receptor antagonist phencyclidine (PCP) to rats followed by a drug washout period would produce enduring cognitive deficits on an attentional set‐shifting task. The task is functionally analogous to a sensitive test of frontal function in humans and non‐human primates. Subchronic PCP administration selectively impaired extradimensional shift learning without affecting other discrimination or reversal tasks. Moreover, acute treatment with the PDE10A inhibitor papaverine immediately prior to testing attenuated the PCP‐induced deficits in extradimensional shift learning across a range of doses. These data suggest that subchronic PCP administration may model effectively some of the cognitive deficits that are observed in schizophrenia, and that PDE10A inhibition may be an effective therapeutic route to improve executive function deficits associated with schizophrenia.Keywords
This publication has 46 references indexed in Scilit:
- Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shiftingEuropean Journal of Neuroscience, 2004
- Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine lossPharmacology Biochemistry and Behavior, 2004
- Inhibition of the Phosphodiesterase 4 (PDE4) Enzyme Reverses Memory Deficits Produced by Infusion of the MEK Inhibitor U0126 into the CA1 Subregion of the Rat HippocampusNeuropsychopharmacology, 2004
- What Are the Right Targets for Psychopharmacology?Science, 2003
- Aged Rats Are Impaired on an Attentional Set-Shifting Task Sensitive to Medial Frontal Cortex Damage in Young RatsLearning & Memory, 2002
- Effects of Ketamine in Normal and Schizophrenic VolunteersNeuropsychopharmacology, 2001
- Impaired Inhibition of Conditioned Responses Produced by Subchronic Administration of Phencyclidine to RatsNeuropsychopharmacology, 2001
- The Neurodevelopmental Frontostriatal Disorders: Evolutionary Adaptiveness and Anomalous LateralizationBrain and Language, 2000
- Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of PhencyclidineScience, 1997
- Dissociation in prefrontal cortex of affective and attentional shiftsNature, 1996